Management of neuronopathic Gaucher disease: revised recommendations.
J Inherit Metab Dis
; 32(5): 660-664, 2009 Oct.
Article
em En
| MEDLINE
| ID: mdl-19655269
ABSTRACT
The original guidelines drawn up for the management of the neuronopathic forms of Gaucher disease were felt to be in need of revision; in particular, the role of high-dose enzyme replacement therapy (120 IU/kg of body weight every 2 weeks) in stabilizing neurological disease. The existing published evidence was analysed; it was concluded that it did not support the role of high-dose ERT, although this might be required to treat severe visceral disease.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Doença de Gaucher
/
Diretrizes para o Planejamento em Saúde
Idioma:
En
Ano de publicação:
2009
Tipo de documento:
Article